Login / Signup

ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.

Till HolstenAnnika BronsemaDominik SturmFelix SahmStefan RutkowskiUlrich SchüllerWilhelm WößmannUwe R Kordes
Published in: Pediatric blood & cancer (2022)
Keyphrases
  • advanced non small cell lung cancer
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • blood brain barrier
  • epidermal growth factor receptor